Literature DB >> 29485069

CTV Guidance for Head and Neck Cancers.

Beth M Beadle1, Carryn M Anderson2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29485069      PMCID： PMC7332112          DOI： 10.1016/j.ijrobp.2017.12.264

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  9 in total

1.  Heterogeneity in head and neck IMRT target design and clinical practice.

Authors:  Theodore S Hong; Wolfgang A Tomé; Paul M Harari
Journal:  Radiother Oncol       Date:  2012-03-09       Impact factor: 6.280

2.  Validated guidelines for tumor delineation on magnetic resonance imaging for laryngeal and hypopharyngeal cancer.

Authors:  Elise Anne Jager; Hans Ligtenberg; Joana Caldas-Magalhaes; Tim Schakel; Marielle E Philippens; Frank A Pameijer; Nicolien Kasperts; Stefan M Willems; Christiaan H Terhaard; Cornelis P Raaijmakers
Journal:  Acta Oncol       Date:  2016-09-08       Impact factor: 4.089

3.  Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy.

Authors:  Allen M Chen; Megan E Daly; D Gregory Farwell; Esther Vazquez; Jean Courquin; Derick H Lau; James A Purdy
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-02       Impact factor: 6.223

4.  Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy.

Authors:  Isabel J Boero; Anthony J Paravati; Beibei Xu; Ezra E W Cohen; Loren K Mell; Quynh-Thu Le; James D Murphy
Journal:  J Clin Oncol       Date:  2016-01-04       Impact factor: 44.544

5.  Prospective observer and software-based assessment of magnetic resonance imaging quality in head and neck cancer: Should standard positioning and immobilization be required for radiation therapy applications?

Authors:  Yao Ding; Abdallah S R Mohamed; Jinzhong Yang; Rivka R Colen; Steven J Frank; Jihong Wang; Eslam Y Wassal; Wenjie Wang; Michael E Kantor; Peter A Balter; David I Rosenthal; Stephen Y Lai; John D Hazle; Clifton D Fuller
Journal:  Pract Radiat Oncol       Date:  2014-12-17

6.  Dynamic MRI analysis of tumor and organ motion during rest and deglutition and margin assessment for radiotherapy of head-and-neck cancer.

Authors:  Julie A Bradley; Eric S Paulson; Ergun Ahunbay; Christopher Schultz; X Allen Li; Dian Wang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-02-06       Impact factor: 7.038

7.  Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.

Authors:  Christopher M Nutting; James P Morden; Kevin J Harrington; Teresa Guerrero Urbano; Shreerang A Bhide; Catharine Clark; Elizabeth A Miles; Aisha B Miah; Kate Newbold; MaryAnne Tanay; Fawzi Adab; Sarah J Jefferies; Christopher Scrase; Beng K Yap; Roger P A'Hern; Mark A Sydenham; Marie Emson; Emma Hall
Journal:  Lancet Oncol       Date:  2011-01-12       Impact factor: 41.316

8.  Improved survival using intensity-modulated radiation therapy in head and neck cancers: a SEER-Medicare analysis.

Authors:  Beth M Beadle; Kai-Ping Liao; Linda S Elting; Thomas A Buchholz; K Kian Ang; Adam S Garden; B Ashleigh Guadagnolo
Journal:  Cancer       Date:  2014-01-13       Impact factor: 6.860

9.  Uncertainties in target volume delineation in radiotherapy - are they relevant and what can we do about them?

Authors:  Barbara Segedin; Primoz Petric
Journal:  Radiol Oncol       Date:  2016-05-09       Impact factor: 2.991
  9 in total
  1 in total

1.  Is a high-risk clinical target volume required? Evaluation of the dosimetric feasibility based on T staging.

Authors:  Xingxing Yuan; Chao Yan; Shiyi Peng; Zhiping Chen; Tianzhu Lu; Qiaoying Gong; Yang Qiu; Wenming Xiong; Fenghua Ao; Guoqing Li; Jingao Li; Ziwei Tu
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.